2 ASX 200 shares newly upgraded this week

After major company news this week, one stock fell 39% while the other spiked 17%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After announcing big company news this week, two S&P/ASX 200 Index (ASX: XJO) shares have been upgraded by the experts.

One stock fell 39% after its earnings guidance was downgraded, while the other spiked 17% after a new operating model was unveiled.

Let's recap what happened, and what the new ratings are for these ASX 200 shares.

A happy couple drinking red wine in a vineyard.

Image source: Getty Images

Cochlear Ltd (ASX: COH

Cochlear shares were smashed this week after the hearing implant device maker downgraded its earnings guidance.

The company now expects an FY26 underlying net profit of $290 million to $300 million, down from $435 million to $460 million.

Cochlear cited capacity constraints at hospitals, falling consumer confidence globally, and cancelled procedures in the Middle East.

The company said:

Consumer sentiment has declined in key markets, reaching historic lows in the US.

The decline appears to be affecting discretionary healthcare decisions in the adults and seniors segment, adding to demand uncertainty in the near term.  

On top of that, industrial action in Italy and Spain has delayed procedures, and China has lowered its reimbursements to patients.

Morgan Stanley upgraded Cochlear shares to a hold rating following a 39% fall in the share price on the day of the news.

The broker slashed its 12-month price target from $194 to $119.

The Cochlear share price hit a new 52-week low of $95.81 yesterday.

Over the past 12 months, the ASX 200 healthcare share has dropped 64%.

Treasury Wine Estates Ltd (ASX: TWE)

Treasury Wine Estates shares rose sharply this week after the company announced a new regional operating model to raise efficiency.

This ASX 200 wine share has been on the nose with investors and fell to a multi-year low of $3.34 last month.

The company's new model is part of a global transformation program called TWE Ascent.

Treasury Wine will operate four new regional divisions: The Americas, Australia and New Zealand (ANZ) and Europe, Greater China, and Emerging Markets (Rest of Asia, Middle East and Africa).

Treasury Wine Estates CEO Sam Fischer said:

We are reshaping TWE to drive clearer accountability for performance and to enable faster, more market-connected decision-making as a foundation for consistent depletions growth.

Fischer added:

Combining the deep local insight of our in-market teams with the scale and expertise of our global functions will step change in-market execution, whilst retaining our enhanced focus on Penfolds and other priority luxury brands.

Citi likes the look of the plan, and upgraded Treasury Wine Estates shares to a hold rating as a result.

The ASX 200 wine share rose 17% to $4.73 on the day of the announcement. Citi's 12-month price target is $4.25.

Over the past 12 months, the ASX 200 wine share has tumbled 48%.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended Treasury Wine Estates. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »